Direct Meds GLP-1 vs Hims: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher & Publisher
Direct Meds GLP-1 and Hims are tied at 7.9/10. Hims is more affordable at $149/mo vs $297/mo. Choose Direct Meds GLP-1 for users wanting simple, all-inclusive pricing without insuranc. Choose Hims for men who want a well-known publicly-traded brand and fda-appr.
A side-by-side look at Direct Meds GLP-1 and Hims to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Direct Meds GLP-1
#8 of 53Straightforward compounded GLP-1 program with transparent all-inclusive pricing and no hidden fees.
Visit Direct Meds GLP-1Hims
#7 of 53The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership, and has since exited compounded semaglutide for new patients, so the retail lineup is FDA-approved brand only. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.
Visit Hims| Feature | Direct Meds GLP-1 | Hims |
|---|---|---|
| Why each one | Thorough clinical consultations focused on medical-grade patient experience rather than quick-turnaround prescribing. | The only publicly-traded men's telehealth (NYSE: HIMS) with FDA-approved Wegovy via direct Novo Nordisk partnership. Brand-name access plus SEC accountability, but balanced against a 3.0 Trustpilot rating that lags peers. |
| Our Score | 7.9/10 | 7.9/10 |
| Starting Price | $297/mo | $149/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users wanting simple, all-inclusive pricing without insurance | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors |
| Watch out for | Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu | Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable. |
| Ranking | #8 | #7 |
| Get started | Visit Direct Meds GLP-1 | Visit Hims |
Pros & Cons Compared
Direct Meds GLP-1
Pros
- +True all-inclusive pricing, $280/mo covers medication, consultations, shipping, and pharmacy fees with no add-ons
- +Clear dose-based pricing published on their site, no surprise cost increases when titrating up
- +Fast pharmacy fulfillment: most orders ship within 48 hours of provider approval
- +Responsive customer support with live chat available during business hours
Cons
- −Compounded medications only, no brand-name Wegovy, Zepbound, or Ozempic on the menu
- −The $280/mo flat rate sits above Henry Meds ($199) and TrimRx ($149); Direct Meds' own sublingual drops at $179 are the budget path if the premium stings
Hims
Pros
- +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
- +Polished app and web experience, among the best user interfaces in men's telehealth.
- +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.
Cons
- −Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
- −Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
- −Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
- −Generic high-volume support, large patient base means less personalized attention than smaller competitors.
Our Verdict
Direct Meds GLP-1 and Hims are closely matched with identical scores of 7.9/10. If budget is your priority, Hims is from $149/mo compared to Direct Meds GLP-1 at $297/mo for the first month, rises after. Hims offers both brand-name and compounded medications, giving you more flexibility. Choose Direct Meds GLP-1 if you want: users wanting simple, all-inclusive pricing without insurance. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors.
Cheapest in our index
Embody
$69/mo flat rate · 7.3/10 · Compounded
Both Direct Meds GLP-1 and Hims start above the cheapest program we track. Across all 53 providers in our index, that floor is Embody at a flat $69/mo, the same rate at every dose, price checked July 31, 2026. It scores 7.3/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Read Full Reviews
Related comparisons
Other matchups readers comparing Direct Meds GLP-1 or Hims tend to look at next.
- Direct Meds GLP-1 vs Telos RX$249/mo
- Direct Meds GLP-1 vs Willow$299/mo
- Direct Meds GLP-1 vs MyStart Health$299/mo
- Hims vs MEDVi$179/mo
- Hims vs Found$129/mo
- Hims vs AgelessRx$199/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.